Ergoloid Mesylate/Oxitriptan

甲磺酸双氢麦角碱/羟色氨酸

Report date: 2024/07/10 17:52:45
NME

Base Information

Drug NameErgoloid Mesylate/Oxitriptan
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGreece
CombinationsYes Ergoloid MesylateOxitriptan
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPurposeful IKE
China Registration ClassN/A

Develop Information

Active CompaniesPurposeful IKE
Inactive CompaniesN/A
Active IndicationsFragile X Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A